Apex Biotechnology Corp. (1733.TW)
- Previous Close
31.70 - Open
31.35 - Bid 31.10 x --
- Ask 31.15 x --
- Day's Range
31.05 - 31.35 - 52 Week Range
26.40 - 36.25 - Volume
110,829 - Avg. Volume
355,450 - Market Cap (intraday)
3.108B - Beta (5Y Monthly) --
- PE Ratio (TTM)
19.44 - EPS (TTM)
1.60 - Earnings Date --
- Forward Dividend & Yield 1.10 (3.55%)
- Ex-Dividend Date May 17, 2024
- 1y Target Est
--
Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing, and hemosmart gold hemoglobin screening systems. It also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is headquartered in Hsinchu City, Taiwan.
www.apexbio.comRecent News: 1733.TW
View MorePerformance Overview: 1733.TW
Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1733.TW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1733.TW
View MoreValuation Measures
Market Cap
3.17B
Enterprise Value
2.73B
Trailing P/E
19.81
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.62
Price/Book (mrq)
1.79
Enterprise Value/Revenue
1.39
Enterprise Value/EBITDA
10.17
Financial Highlights
Profitability and Income Statement
Profit Margin
8.21%
Return on Assets (ttm)
4.40%
Return on Equity (ttm)
9.24%
Revenue (ttm)
1.96B
Net Income Avi to Common (ttm)
160.88M
Diluted EPS (ttm)
1.60
Balance Sheet and Cash Flow
Total Cash (mrq)
594.77M
Total Debt/Equity (mrq)
6.58%
Levered Free Cash Flow (ttm)
205.17M